COMPANY

Neuropathix

HQ: Doylestown, PA source · neuropathix.com ↗ · Mid-Atlantic

Keywords: neuropathic pain neurology

Location: Doylestown, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Filed a Form D for an offering of up to $50M, no sales reported yet (filed Nov 17, 2025). SEC Form D 0001615999-25-000003 (Nov 17, 2025)
Evidence (1 event)
- Nov 17, 2025 · SEC Form D 0001615999-25-000003
  Name of Issuer: NEUROPATHIX, INC.; CIK: 1615999; Address: Doylestown, PA; Submission type: D; Filing date: 2025-11-17; Industry Group: Biotechnology; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 50000000; Total Amount Sold: 0; Federal exemptions: 06c

Job counts as of Oct 18, 2026. All funding and NIH signals